Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in Circ Res

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    December 2020
  1. HENNIGS JK, Cao A, Li CG, Shi M, et al
    PPARgamma-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
    Circ Res. 2020 Dec 16. doi: 10.1161/CIRCRESAHA.119.316339.
    PubMed     Abstract available


    October 2020
  2. YANG P, Yu PB
    Periostin: A Novel Integrator of Hypoxic Signaling in Pulmonary Hypertension.
    Circ Res. 2020;127:1153-1155.
    PubMed    


    September 2020
  3. JIA D, Bai P, Wan N, Liu J, et al
    Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages.
    Circ Res. 2020 Sep 11. doi: 10.1161/CIRCRESAHA.120.316784.
    PubMed     Abstract available


    August 2020
  4. LEOPOLD JA
    Endocrine Delivery of MicroRNA-210: A Trusted Traveler That Mediates Pulmonary Hypertension.
    Circ Res. 2020;127:693-695.
    PubMed    


    June 2020
  5. ZHAO J, Florentin J, Tai YY, Torrino S, et al
    Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.
    Circ Res. 2020 Jun 4. doi: 10.1161/CIRCRESAHA.119.316398.
    PubMed     Abstract available


    November 2019
  6. BOCHENEK ML, Leidinger C, Rosinus NS, Gogiraju R, et al
    Activated Endothelial TGFbeta1 Signaling Promotes Venous Thrombus Non-Resolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension.
    Circ Res. 2019 Nov 21. doi: 10.1161/CIRCRESAHA.119.315259.
    PubMed     Abstract available


    August 2019
  7. BRITTAIN EL, Hemnes AR
    Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension.
    Circ Res. 2019;125:467-469.
    PubMed    


    July 2019
  8. LAMBERT M, Capuano V, Boet A, Tesson L, et al
    Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.
    Circ Res. 2019 Jul 26. doi: 10.1161/CIRCRESAHA.119.314793.
    PubMed     Abstract available


    June 2019
  9. CALVIER L, Boucher P, Herz J, Hansmann G, et al
    LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARgamma Activation.
    Circ Res. 2019;124:1778-1785.
    PubMed     Abstract available


  10. RANCHOUX B, Nadeau V, Bourgeois A, Provencher S, et al
    Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
    Circ Res. 2019 Jun 3. doi: 10.1161/CIRCRESAHA.118.314555.
    PubMed     Abstract available


    May 2019
  11. ZELT JGE, Chaudhary KR, Cadete VJ, Mielniczuk LM, et al
    Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.
    Circ Res. 2019;124:1551-1567.
    PubMed     Abstract available


    April 2019
  12. GUIGNABERT C, Tu L, Feige JJ, Humbert M, et al
    Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".
    Circ Res. 2019;124:e82-e83.
    PubMed    


  13. MORRELL NW, Upton PD, Li W, Yu PB, et al
    Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".
    Circ Res. 2019;124:e81.
    PubMed    


    March 2019
  14. LEOPOLD JA, Maron BA
    Precision Medicine in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:832-833.
    PubMed    


  15. ORMISTON ML, Godoy RS, Chaudhary KR, Stewart DJ, et al
    The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:822-824.
    PubMed    


  16. SWEATT AJ, Hedlin HK, Balasubramanian V, Hsi A, et al
    Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:904-919.
    PubMed     Abstract available


    January 2019
  17. BABICHEVA A, Yuan JX
    Endothelial Notch1 in Pulmonary Hypertension.
    Circ Res. 2019;124:176-179.
    PubMed    


  18. MIYAGAWA K, Shi M, Chen PI, Hennigs JK, et al
    Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Circ Res. 2019;124:211-224.
    PubMed     Abstract available


  19. TU L, Castan A, Mallet C, Guyon L, et al
    Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
    Circ Res. 2019 Jan 14. doi: 10.1161/CIRCRESAHA.118.313356.
    PubMed     Abstract available


  20. YANG P, Yu PB
    In Search of the Second Hit in Pulmonary Arterial Hypertension.
    Circ Res. 2019;124:6-8.
    PubMed    


    October 2018
  21. ABDUL-SALAM VB, Russomanno G, Chien-Nien C, Mahomed AS, et al
    CLIC4/Arf6 Pathway - A New Lead in BMPRII Inhibition in Pulmonary Hypertension.
    Circ Res. 2018 Oct 15. doi: 10.1161/CIRCRESAHA.118.313705.
    PubMed     Abstract available


    March 2018
  22. TAMOSIUNIENE R, Manouvakhova O, Mesange P, Saito T, et al
    A Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.
    Circ Res. 2018 Mar 15. pii: CIRCRESAHA.117.312058.
    PubMed     Abstract available


    October 2017
  23. MICHELAKIS ED
    PVDOMICS Drive the Pulmonary Hypertension Field Into the Precision Medicine Era.
    Circ Res. 2017;121:1106-1108.
    PubMed    


    August 2017
  24. GOMBERG-MAITLAND M, Souza R
    Uncovering Small Secrets in Big Data Sets: How Math Can Identify Biology in Rare Conditions (Pediatric Pulmonary Hypertension).
    Circ Res. 2017;121:317-319.
    PubMed    


  25. BISCHOFF FC, Werner A, John D, Boeckel JN, et al
    Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes.
    Circ Res. 2017;121:368-375.
    PubMed     Abstract available


    June 2017
  26. ONG MS, Mullen MP, Austin ED, Szolovits P, et al
    Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension.
    Circ Res. 2017 Jun 13. pii: CIRCRESAHA.117.310804.
    PubMed     Abstract available


    March 2017
  27. SATOH T, Satoh K, Yaoita N, Kikuchi N, et al
    Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Circ Res. 2017 Mar 13. pii: CIRCRESAHA.117.310640.
    PubMed     Abstract available


    May 2016
  28. OMURA J, Satoh K, Kikuchi N, Satoh T, et al
    Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice.
    Circ Res. 2016 May 23. pii: CIRCRESAHA.115.308178.
    PubMed     Abstract available


    March 2016
  29. DIERICK F, Hery T, Hoareau-Coudert B, Mougenot N, et al
    Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension.
    Circ Res. 2016;118:822-33.
    PubMed     Abstract available


    October 2015
  30. DENG L, Blanco FJ, Stevens H, Lu R, et al
    MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
    Circ Res. 2015;117:870-83.
    PubMed     Abstract available


    September 2015
  31. GURTU V, Michelakis E
    Cell-Based Gene Therapy in Pulmonary Arterial Hypertension: Journeys in Translational Medicine.
    Circ Res. 2015;117:596-8.
    PubMed    


  32. GRANTON J, Langleben D, Kutryk MB, Camack N, et al
    Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.
    Circ Res. 2015;117:645-54.
    PubMed     Abstract available


    August 2015
  33. MELOCHE J, Potus F, Vaillancourt M, Bourgeois A, et al
    Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.
    Circ Res. 2015;117:525-35.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: